Gemcitabine

Urology # 320Jul 31, 2026

Gem-iDRS for BCG Unresponsive Bladder Cancer: A Deep Dive

with Dr. Sarah Psutka, Dr. Ruchika Talwar

Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology, Dr. Ruchi Talwar interviews Dr. Sarah Psutka to explore the emerging role of a novel intravesical device that delivers sustained gemcitabine therapy for patients refusing or ineligible for cystectomy. They highlight new FDA-approved treatment options, real-world workflow considerations, and the clinical potential for continuous intravesical chemotherapy in a crowded therapeutic landscape.

Tumor Board # 25Oct 7, 2025

Guide to Patient-Centered Counseling in NMIBC Care

with Dr. Sima Porten, Dr. Patrick Hensley, Dr. Vignesh Packiam

When a patient is diagnosed with non-muscle invasive bladder cancer (NMIBC), how do you tailor the conversation and treatment plan to their individual needs (and fears)? In part two of the 2025 NMIBC Creator Weekend™ series, host Dr. Vignesh Packiam is joined by Dr. Sima Porten from UCSF and Dr. Patrick Hensley from the University of Kentucky to discuss patient-centered diagnostic and therapeutic approaches for non-muscle invasive bladder cancer.